RSS

European Union (EU)

The European Medicines Agency (EMA), together with the Heads of Medicines Agencies (HMA) guide marketing authorisation holders (MAH) on how to address medicinal product shortages. Read more

News

Here, Karen Rossington and Siobhan Murphy from Contec guide readers through the implications of the EU Biocidal Products Regulation (BPR) on life science cleanroom users. Read more

, Opinion

A “Norway Plus” Brexit will be the least damaging to the pharmaceutical manufacturing sector, according to an industry logistics expert. Read more

News

Data and analytics company, GlobalData, has revealed that recent survey findings from the European Medicines Agency (EMA) into Brexit preparedness of the pharma industry support its own conclusions on the matter. Read more

Analysis

The Association of the British Pharmaceutical Industry (ABPI) has issued its reaction to the publication of the Medicines and Healthcare products Regulatory Agency’s (MHRA) update to pharma companies on preparing for Brexit. Read more

News

Despite concern expressed by the pharmaceutical industry that the UK would suffer as a result of Brexit, Catalyst Corporate Finance, the UK business of Alantra, argues that the UK’s decision to leave the European Union in fact Read more

Opinion

Associations that represent both the European and British life sciences industries have urged the UK and European member states to secure cooperation post-Brexit so that access to medicine for patients can be safeguarded. Read more

News

We have now had a few days to digest the outcome of the relocation vote that took place on Monday 20 November, revealing that the European Medicines Agency (EMA) will be relocated to Amsterdam. But, what should we expect from this relocation? Read more

News

Today (Monday 20 November) is the day that will see the first vote on the new location of the European Medicines Agency (EMA) be made by European Union (EU) ministers. Read more

News

Scottish biotechnology company, TC BioPharm (TCB), has been selected to receive a €4 million grant from the European Union’s (EU’s) research and innovation programme, Horizon 2020. Read more

News

Global contract development and manufacturing organisation (CDMO), Almac Group, has announced two events to discuss the key aspects surrounding launching a product in the European market. Read more

News

Dr Prashanth BSB, head of safety and medical writing for ELC Group, talks to EPM about the ramifications Brexit may have on the pharmacovigilance landscape. Read more

Opinion

Dermatology specialist, LEO Pharma, has announced that the European Commission (EC) has granted marketing authorisation for its new biologic, Kyntheum (brodalumab), for the treatment of moderate-to-severe plaque psoriasis in adults within the EU. Read more

News

With the implementation of the new European Union In Vitro Diagnostic Regulation (EU IVDR) commencing, questions have been raised on companion diagnostic (CDx) development, which were assessed at a recent meeting held by ARC Regulatory. Read more

News

A joint letter has been written by the chief executive of the ABPI and seven other UK and European pharma and life science industry bodies for the UK and EU Brexit negotiations teams, underlining the importance of ongoing cooperation on medicines. Read more

News

New research, published by EEF, has revealed that many export destinations are not as open to trade as they were prior to the financial crisis, making it vital the government the government ensures barrier free trade Read more

News

ABPI responds positively to a letter in the Financial Times from health secretary, Jeremy Hunt, and business secretary, Greg Clark, which lays out plans for the regulation of medicines in the UK after the country leaves the European Union. Read more

News

The manufacturers’ organisation, EEF, has warned of a potential recruitment crunch if Britain’s businesses are denied access to skills from across the European Union, which is highlighted in its report published today. Read more

News

In his keynote speech during the 2017 BIO Convention in San Diego, former prime minister David Cameron has discussed the future of medicines regulation in Europe after the UK leaves the EU, reports the UK BioIndustry Association (BIA). Read more

News

In this article, Mark Usher of Solidsoft Reply, explains the challenges of deploying multiple connected national systems for the large-scale European pharmaceutical industry. Read more

Opinion